"Raise awareness of pharmacies as places of primary health care provision," advocates the International Pharmaceutical Federation (FIP), emphasising the
need for universal recognition of pharmacists as essential healthcare professionals.
Despite significant advancements in pharmacy practice, many policymakers and members of the public still view pharmacies primarily as commercial enterprises
rather than essential providers of healthcare services.
The FIP is leading a campaign to change this perception, advocating for pharmacies to be recognised as vital components of primary health care.
Primary health care is crucial for achieving "health for all."
In 2018, the Declaration of Astana saw governments recommit to strengthening primary health care to achieve universal health coverage.
FIP, a signatory to this declaration, has since been dedicated to enhancing the role and impact of pharmacies in primary health care.
There is no doubt that the pandemic has changed the way healthcare professionals work within the primary care setting. The advent of Covid-19 meant that we all
had to rapidly modify the way we supported and met the needs of patients, some of whom saw the services they usually took for granted, virtually cease overnight.
There are around 15 million people in England living with long-term health conditions including asthma. These people have the greatest healthcare needs of the whole
population with 50 per cent of all GP appointments and 70 per cent of all bed days taken by this cohort of patients, and their treatment and care absorbing 70 per
cent of acute and primary care budgets in England.
This situation isn't going to improve any time soon. In the past, most people had a single condition, today multi-morbidity is becoming the norm. At the start of the
pandemic, the Royal College of General Practice and British Medical Association issued guidance to practices on prioritising workload. This included the importance
of maintaining long-term condition reviews in asthma, COPD and diabetes, along with appropriate transition of at-risk warfarin patients. These reviews were deemed as
essential workstreams for patients considered to be at high risk.
Traditionally, the unique skills set of a pharmacist has meant that we have played a major role in supporting these patients. I work with a team of over 90 clinical
pharmacists who, in partnership with individual practices, PCNs, CCGs and STPs, help with the long-term management of people with chronic conditions. But the onset
of Covid-19 meant that we now had to plug a potential gap in service provision, and quickly.
The Royal Pharmaceutical Society (RPS) in England has published a review of its 10-year Vision for Pharmacy Professional Practice that was launched in
December 2022 in collaboration with The King's Fund.
The 'one year on' vision report highlighted key milestones achieved in the first 12 months since its publication as well as opportunities for further progress.
It identified the publication of the NHS Long Term Workforce Plan, which recognises the significant role that pharmacists play in healthcare and commits to growing
and expanding the pharmacy workforce, as one of the positive policy developments made since the launch of the vision.
The development of a Vision for Community Pharmacy by Community Pharmacy England, the Nuffield Trust and The King's Fund; work on digital integration to enable
community pharmacists to update a clinical record; the launch of Pharmacy First scheme; and the publication of the public consultation of pharmacy supervision
were other key milestones mentioned in the report.
UK-based consumer health company Kenvue has developed a series of tools and materials to support healthcare professionals - including pharmacy teams - with
their conversations with smokers on their quit journey.
This is part of their newly launched Smokefree Families initiative, which aims to help reduce the number of smoking households with children in England.
Kenvue believes that pharmacists and their teams are vital to the success of this initiative, as they play a crucial role in supporting smokers in their quit
journey.
"As trusted sources of support and advice to families across the country, we firmly believe that community pharmacy teams are crucial to the success of our Smokefree
Families initiative," Manoj Raghunandanan, Area Managing Director, Northern Europe at Kenvue, told Pharmacy Business.
"To support them, we've created a series of tools and materials that can help pharmacists and other healthcare professionals tackle sensitive conversations with
new and expectant parents, their partners and support networks, and ultimately motivate them on their quit journey."
National pharmacy bodies have called on the government and NHS leaders to take appropriate action to keep pharmacy teams safe from violence and abuse.
The Pharmaceutical Services Negotiating Committee (PSNC) - in collaboration with the Association of Independent Multiple Pharmacies (AIMp), the Company Chemists'
Association (CCA), the National Pharmacy Association (NPA), and the Royal Pharmaceutical Society (RPS) - is supporting an important petition started by Mike Hewitson,
a community pharmacy contractor, who has been threatened with stabbing and robbed in his own pharmacy.
The PSNC and the other national pharmacy bodies strongly believe that no healthcare professional should have to deal with this, that and pharmacists and their teams
should be better protected.
It said: "Community pharmacies play an integral role in the delivery of primary care and most patients are highly appreciative of the hard work of local pharmacists
and pharmacy teams from dispensing medicines and administering vaccines to providing medical advice and health monitoring services.
Community pharmacy could play an important role in proactive detection of heart valve disease (HVD), which remains under-recognised and under-detected in
England, suggested a new report published by Wilmington Healthcare.
Pharmacy bodies, including Royal Pharmaceutical Society (RPS), National Pharmacy Association (NPA) and Community Pharmacy England (CPE), have also endorsed the
report, which encourages Integrated Care Boards (ICBs) to consider the innovative approach of detecting HVD with the help of community pharmacists.
Despite HVD detection being a priority listed in the NHS Long Term Plan, a large number of people with HVD remained undiagnosed and untreated in the country due
to lack of awareness of the disease prevalence.
In June 2022, a pilot study was launched in Farnborough Primary Care Network (PCN), Hampshire, to evaluate the feasibility of using e-stethoscopes
(digital auscultation) to detect this heart condition by a community pharmacist.
A community pharmacist, Viral Doshi was honoured with the British Citizen Award (BCA) on Thursday (26 January) at the Palace of Westminster for transforming
his community centre into vaccination hub during Covid-19 pandemic.
Viral was presented with his Medal of Honour by Liam Sargeant, Senior Company Communications Manager, from supporters P&G and TV presenter and Patron of the BCA,
Nick Knowles, who hosted the event.
At the height of the pandemic, Viral obtained approval to transform his community centre into a vaccination hub. Located in the heart of a multi-ethnic population,
with social deprivation, surrounded by wards experiencing high rates of Covid-19. His determination to increase uptake and reduce vaccination hesitancy, led to
80,000 vaccinations being administered, the overall highest vaccination uptake in North West London.
Viral is a passionate advocate for the role that GP practices and community pharmacies can play in supporting the health agenda. His objective, to provide better
choice and access for the community have been fully met and appreciated by patients. His initiatives led to a dramatic increase in the clinical skills, knowledge
and services offered by local community pharmacies around a variety of health topics. This enabled pharmacies to adopt a holistic health approach to working with
their communities.
"Only around half of ICSs have a Chief Pharmacist," indicating a significant gap in leadership that hampers the pharmacy sector's ability to influence
critical healthcare decision, a report on medicine optimisation by the Public Policy Projects (PPP) highlights.
In PPP's latest report, a notable concern highlighted is the inadequate representation of pharmacy leadership within Integrated Care Systems (ICSs) despite the
role of pharmacy being "central in the delivery of system priorities, with pivotal roles in improving population health and tackling inequalities".
In recent years, the role of pharmacy within the NHS has evolved significantly with recent developments including Pharmacy First Services and legislative
amendments that allows pharmacy technicians under PGDs to administer and supply medicines.
Prime Minister Rishi Sunak, during today's (15th May ) Prime Minister's Questions (PMQs), reiterated his commitment to supporting community pharmacies amidst
growing concerns over pharmacy closures.
Addressing questions regarding the Pharmacy First initiative, Sunak assured the House of Commons of his dedication to bolstering resources for these vital healthcare
providers.
In response to a query raised by Member of Parliament, St Ives MP Derek Thomas, citing statistics from the National Pharmacy Association (NPA) about "committing to
directing funds towards Community Pharmacy to alleviate financial pressure and prevent closures, Sunak remarked that he "cares deeply about the future of community
pharmacies."
Sunak acknowledged the indispensable role played by community pharmacists in alleviating pressure on urgent care services, emphasising the importance of initiatives
like Pharmacy First in government's commitment to supporting community pharmacies.
"There are over 10 and a half Community pharmacies across the country working incredibly hard to serve their patients," Sunak said praising the community pharmacists
and highlighted the concerning trend of pharmacy closures, citing a significant increase compared to the previous year.
The pharmacy inquiry will explore issues impacting different types of pharmacy, with a particular focus on community, primary care and hospital pharmacy
services.
It will also consider current challenges around funding, workforce and the digital infrastructure.
Planned developments within the profession will enable future pharmacists to be independent prescribers from day one of registration, giving them a greater role
within primary care teams.
Health and Social Care Committee Chair Steve Brine MP said: "It is clear that pharmacy has a central role to play in the future of the NHS. With a greater focus on
personalised and patient-centred healthcare, we will be asking what more must be done to make sure that the profession is in the best shape to meet demand.
"Better use of the pharmacy workforce would reduce pressures on general practice and hospitals. However, this will not happen without a planned workforce with the
funding, supervision and training to support it.
"At the end of the inquiry, the committee will be making recommendations to the government on what action needs to be taken to ensure the potential of pharmacy is
realised.
In a delightful announcement, the University of Brighton has honoured NHS England's Chief Pharmaceutical Officer, David Webb with its prestigious Doctor
of Science honorary degree
Webb's award is a highlight of the university's graduation ceremony which celebrated the graduation of over 3,400 undergraduate and postgraduate students from 92
countries at the Brighton Centre this week.
The accolade recognises Webb's transformative work in the pharmacy services within the NHS, highlighting the profound impact his contributions have had on delivery
of healthcare across the UK.
Under Webb's leadership, significant advancements have been made in integrating pharmacy into NHS care pathways, improving patient outcomes, and enhancing the role
of pharmacists and pharmacy technicians in the healthcare system.
Webb expressed his honour stating, "I am delighted to receive the honorary award of Doctor of Science from the University of Brighton in recognition of both my
contribution to pharmacy in the NHS"
Over the last few years, we've seen the aftermath of Covid-19, with the demand for consumer health products being unprecedented and unpredictable, placing
pressure on supply chains and labour market. In turn, the industry has experienced acute shortages across the healthcare sector, placing huge pressure on
pharmacists, doctors, nurses, and other healthcare professionals.
Europe has an estimated shortage of around 50,000 public-sector doctors[1], which is set to increase in the coming years. While this shortage stems from several
complex problems, there is a hidden force that could play a key part in helping to alleviate this burden. That force is the potential of self-care.
Encouragingly, last month the UK government recognised the unique role that self-care can play through the introduction of its Delivery plan for recovering access
to primary care. Through this, it has pledged to empower patients to manage their own health through several commitments, including improving accessibility to
online tools and reclassifying medicines to make formerly prescribed options available over the counter.
The International Pharmaceutical Federation (FIP) has issued a new policy statement which encourages a "life-course" approach to vaccination by pharmacists.
In the statement, published on September 27, FIP backed expansion of vaccine schedules and strategies so that patients of all age groups could be vaccinated
throughout their entire lifespan, from infancy to old age.
A life-course approach in public health and healthcare focuses on an individual's health and well-being, including vaccination, administered throughout their
entire lifespan, from infancy to old age.
FIP urged governments and policymakers to eliminate regulatory barriers, enabling pharmacists to prescribe and administer all relevant vaccines throughout the
life-course. Additionally, FIP recommended that policymakers develop remuneration models for pharmacies to deliver sustainable life-course vaccination services
within the private and public sectors.
The Pharmacists' Defence Association (PDA) has raised the issue faced by the pharmacy students on returning to in-person assessments while urging the
universities to take an empathetic approach in transition of online to in-person exams.
It was highlighted by the association that many student members were apprehensive about the return to in-person assessments. This is due to their continuing worry of Covid-19 transmissions and anxiety caused by changing exam formats and procedures.
However, with the ease of Covid restrictions, now pharmacy schools are able to decide how exams are conducted but the PDA believes that they should communicate the
process to students in advance.
"A return to normal university life is considered to be beneficial to student health and well-being. In-person exams are an important part of preparing for students' future trainee assessment examinations, GPhC accreditation for pharmacy schools, and ensuring the integrity of exam results. As future healthcare professionals, face-to-face interaction is also an integral part of the role," said the PDA.
It's no secret that as pharmacists we are navigating a new and more demanding healthcare landscape. Our role has changed significantly since the start of the 21st century due to increased expectations from the public, advances in science and technology and changing workforce pressures.
The Community Pharmacy Contractual Framework for England has placed a higher focus on clinical service. In addition, the Covid-19 pandemic resulted in significant
acceleration in changing how we work day-to-day and the public perception of our role.
Community pharmacy owners and staff have been under relentless pressure for the last two years. Dispensing volumes are continually increasing but dispensing revenues
are being replaced by launching new services. We must find solutions to reduce the time it takes to dispense medication so we can focus on these new revenue generating services.
To not just succeed, but to thrive, it is becoming increasingly important to understand and embrace the technology available.
In a collaborative effort, the National Health Services England (NHSE) is set to deliver the RSV(respiratory syncytial virus) vaccination programme where
pharmacists alongside other healthcare professionals will play a crucial role in administering the vaccine.
The UK Health Security Agency has announced the launch of the new vaccination programme targeting the respiratory syncytial virus (RSV), set to begin on 1 September
2024.
Along with GPs, NHS England (NHSE) will "commission a number of community pharmacies to deliver the programme", ensuring broad accessibility and coverage to protect
two high-risk groups: older adults and pregnant women.
RSV is an RNA virus related to mumps, measles, and human parainfluenza viruses.
It commonly causes coughs and colds in winter, transmitted through droplets and secretions from close contact with infected individuals.
While most RSV infections are mild, infants under six months and the elderly are particularly susceptible to severe diseases like bronchiolitis and pneumonia,
which can lead to hospitalisation.
Pharmacists from BAME backgrounds still face higher levels of discrimination, harassment, bullying, and career obstacles compared to their white
counterparts, the Pharmacy Workforce Race Equality Standard (PWRES) report has revealed. Published by NHSE England, this report underscores the persistent
presence of inequality, emphasising the crucial need for all stakeholders in the pharmacy sector to prioritise addressing these issues.
The PWRES report indicates that pharmacy team members of Black ethnic backgrounds are less likely to perceive equal opportunities for career advancement or
promotion within their trust. Additionally, female pharmacy team members from BAME backgrounds report higher incidents of personal discrimination in the
workplace. The report also highlights an overrepresentation of pharmacy technicians from BAME backgrounds in lower-paid roles.
"It is shocking and unacceptable to see that across all indicators the BME staff experience is worse than their white counterparts," said Tase Oputu, Chair
of RPS in England.
The National Pharmacy Association (NPA) highlighted the role played by community pharmacies during pandemic to provide urgent care and vital support to people
with long-term medical conditions at its opening remark in the Covid-19 public inquiry held on Tuesday (28 February).
NPA is the core participant in the Covid-19 public inquiry. lawyer Brian Stanton made an opening statement on the NPA's behalf which focused on three areas- health
inequalities and the needs of vulnerable patients; the impact of medicine shortages and medicine price increases and the challenge that community pharmacy faced in
responding to the pandemic and maintaining patient services following long-term under investment.
Stanton said: "The UK's community pharmacies were on the frontline of efforts to limit the impact of coronavirus and to keep people well, and as well as handling a
massive increase in demand for healthcare advice and medicines, they also continued to provide urgent care and vital support to people with long-term medical
conditions.
"However, there are now very many at risk of closure during to underfunding and when the Inquiry comes to consider its recommendations the NPA would encourage
you [the presiding judge] to think about how resilience can be built into future plans."
The statement included a compelling account of the commitment typical of so many pharmacies during the pandemic - from husband and wife Pete and Sukhi Johal, both
NPA members and pharmacists, who co-own Calow Pharmacy in Chesterfield.
The National Pharmacy Association (NPA) has emphasised that the community pharmacy sector must be involved right from the start in all local planning meetings
pertaining to the roll-out of vaccine services in potential future pandemics. This includes crucial discussions regarding supply logistics and resource allocation,
lawyers representing the NPA told COVID-19 public inquiry hearing.
Chaired by Baroness Heather Hallett, the independent public inquiry is examining the UK's response to the Covid-19 pandemic and lessons for the future.
The NPA has been designated as a 'core participant' in Module 4 (vaccines) of the inquiry, which considers various issues related to vaccine development and rollout,
as well as Module 3 (healthcare).
During the hearing on September 13, NPA lawyers outlined three key areas the association says must be improved in future pandemic vaccination programs, including
properly utilising existing primary care expertise, better planning and engagement, and improved access to information for community pharmacists.
Prostate cancer is the most common cancer among men in the United Kingdom, affecting nearly 50,000 men yearly. Combined with the challenges faced across
healthcare during COVID-19, new figures show that prostate cancer accounts for a third of cancers not treated due to the pandemic, with 14,000 'missing patients'
believed to have not undergone treatment since April 2020. It is more urgent than ever that men are encouraged to get checked, as any set-backs in diagnosis can
reduce the pathways available, in turn affecting health outcomes.
Community pharmacy teams play a crucial role in signposting the help available for men who may be concerned about their health. Therefore, it is vital that pharmacy
teams have access to the information they need to correctly direct men to seek prostate cancer guidance. By maximising the trusted relationship between patients and their pharmacists, more can be done to identify the warning signs, helping men to get an earlier diagnosis.